Docebo Inc. (DCBO) Tops Q4 EPS by 10c, provides guidance

Docebo Inc. (NASDAQ: DCBO) reported Q4 EPS of $0.45, $0.10 better than the analyst estimate of $0.35. Revenue for the quarter came in at $63 million versus the consensus estimate of $62.06 million.

GUIDANCE:

Docebo Inc. sees Q1 2026 revenue of $63.5-63.7 million, versus the consensus of $63.416 million.

Docebo Inc. sees FY2026 revenue of $267.5-269.5 million, versus the consensus of $268.8 million.

For earnings history and earnings-related data on Docebo Inc. (DCBO) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• CrowdStrike shares jump on earnings beat, raised outlook
• Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance